Posts

Ataxia Telangiectasia (AT) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Ataxia Telangiectasia (AT) Market Outlook Thelansis’s “Ataxia Telangiectasia (AT) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Ataxia Telangiectasia (AT) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Ataxia Telangiectasia (AT) Overview Ataxia telangiectasia (AT), also known as Louis-Bar syndrome, is a rare genetic disorder caused by mutations in the ataxia telangiectasia mutated (ATM) gene located on chromosome 11q22-23. These mutations result in a loss of function of the ATM protein, which plays a crucial role in cellular DNA repair, cell cycle control, and cellular response to external triggers such as ionizing radiation...
Post a Comment
Read more

Chronic Gout – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Chronic Gout Market Outlook Thelansis’s “Chronic Gout Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Chronic Gout treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Chronic Gout Overview Gout is a disorder of purine metabolism that causes hyperuricemia and generally refers to a form of arthritis. The first symptoms include intense pain in only one hallux joint in 90% of the cases. The elevated blood uric acid level in men (serum-urate level >7 mg/dl) and in women (serum-urate level >6) results in the formation of monosodium urate (MSU) crystals and deposition in joint bones and subcutaneous tissue. Hyperuricemia is not the ...
Post a Comment
Read more

Functional Constipation (FC) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Functional Constipation (FC) Market Outlook Thelansis’s “Functional Constipation (FC) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Functional Constipation (FC) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Functional Constipation (FC) Overview Functional constipation (FC) is a condition that is diagnosed according to the Rome IV criteria. It involves the presence of two or more of the following symptoms: straining during at least 25% of defecations, lumpy or hard stools in at least 25% of defecations, the sensation of incomplete evacuation for at least 25% of defecations, the sensation of anorectal obstruction/blockage for...
Post a Comment
Read more

X-Linked Recessive Ichthyosis (XLRI) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

X-Linked Recessive Ichthyosis (XLRI) Market Outlook Thelansis’s “X-Linked Recessive Ichthyosis (XLRI) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential X-Linked Recessive Ichthyosis (XLRI) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). X-Linked Recessive Ichthyosis (XLRI) Overview X-linked ichthyosis (XLI) is a skin disorder caused by a genetic deficiency in the STS gene located on the X chromosome. This leads to abnormal shedding of the skin, resulting in dry and scaly skin with polygonal scales. The condition is typically diagnosed in the first year of life, with some cases manifesting at birth. However, the flexures, palms, a...
Post a Comment
Read more

Polymyalgia Rheumatica (PMR) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Polymyalgia Rheumatica (PMR) Market Outlook Thelansis’s “Polymyalgia Rheumatica (PMR) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Polymyalgia Rheumatica (PMR) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Polymyalgia Rheumatica (PMR) Overview Polymyalgia rheumatica (PMR) is a prevalent inflammatory disorder of unknown origin that predominantly affects elderly individuals from Western countries. It is characterized by intense pain and stiffness involving the shoulders, proximal areas of the arms, neck, pelvic girdle, and proximal regions of the thighs. Patients with PMR commonly experience morning stiffness lasting more th...
Post a Comment
Read more

HER2-Positive Metastatic Breast Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

HER2-Positive Metastatic Breast Cancer Market Outlook Thelansis’s “HER2-Positive Metastatic Breast Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential HER2-Positive Metastatic Breast Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). HER2-Positive Metastatic Breast Cancer Overview HER2-Positive Metastatic Breast Cancer is characterized by the overexpression and amplification of the human epidermal growth factor receptor 2 (HER2). It is a highly aggressive subtype with unfavorable survival prospects. Approximately 15% to 20% of breast cancers exhibit amplification of the HER2 gene, which is linked to an elevated risk of s...
Post a Comment
Read more

Excessive Daytime Sleepiness (EDS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Excessive Daytime Sleepiness (EDS) Market Outlook Thelansis’s “Excessive Daytime Sleepiness (EDS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Excessive Daytime Sleepiness (EDS) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Excessive Daytime Sleepiness (EDS) Overview Adults spend approximately one-third of their lives sleeping, a crucial activity vital for memory consolidation, immune system rejuvenation, and other essential bodily functions. Excessive daytime sleepiness manifests as challenges in maintaining alertness or wakefulness, often accompanied by a strong inclination to sleep during sedentary activities like drivi...
Post a Comment
Read more